This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various pharmaceutical agents, particularly those targeting central nervous system disorders. Its structural features, including the difluoropyrrolidine and piperidine moieties, make it a valuable building block for designing molecules with enhanced bioavailability and receptor binding affinity. Researchers often employ it in the development of potential therapeutics for conditions such as depression, anxiety, and neurodegenerative diseases. Additionally, its use in the optimization of drug candidates for improved pharmacokinetic properties highlights its importance in modern drug discovery pipelines.